Ranbaxy Lab gains despite LIC offloading 2% stake in company

24 Dec 2013 Evaluate

Ranbaxy Laboratories is currently trading at Rs. 464.95, up by 9.45 points or 2.07 % from its previous closing of Rs. 455.50 on the BSE.

The scrip opened at Rs. 456.50 and has touched a high and low of Rs. 465.50 and Rs. 455.70 respectively. So far 91265 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 525.00 on 03-Jan-2013 and a 52 week low of Rs. 253.95 on 02-Aug-2013.

Last one week high and low of the scrip stood at Rs. 462.25 and Rs. 418.25 respectively. The current market cap of the company is Rs. 19697.64 crore.

The promoters holding in the company stood at 63.51 % while Institutions and Non-Institutions held 19.46 % and 14.29 % respectively.

State-owned LIC has cut its stake in Ranbaxy Laboratories by selling more than 2% stake over the past five years. The country’s largest insurer offloaded 45,08,036 shares of Ranbaxy between October 15, 2008 and December 20, 2013 through open markets.

Following the stake sale, LIC’s stake in the company has come down to 6.13% from 8.15%.

During the period from October 15, 2008 and December 20, 2013, Ranbaxy was taken over by Japan’s Daiichi Sankyo. The company was also in various regulatory troubles during this period.

Ranbaxy Laboratories, India’s largest pharmaceutical company, is an integrated, research based, international pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies.

Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×